Newsroom category: Ozempic News

Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION)

December 17, 2025

Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION) The U.S. Judicial Panel on Multidistrict Litigation has ordered the creation of a new federal multidistrict litigation consolidating lawsuits alleging that popular GLP-1 receptor agonist drugs caused patients to suffer serious vision injuries, including non-arteritic anterior ischemic optic neuropathy, […]

Read More

Novo Nordisk CEO Blames PBMs for Ozempic/Wegovy High Prices

September 25, 2024

The spotlight on pharmaceutical giant Novo Nordisk shifted this week from Ozempic/Wegovy gastroparesis lawsuits to a grilling on the drugs’ prices. On Tuesday, the company’s CEO, Lars Fruergaard Jørgensen, faced intense scrutiny during a U.S. Senate hearing over the high cost of the company’s popular diabetes and weight-loss drugs. While senators criticized the corporation for […]

Read More